Navigation Links
Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
Date:6/11/2008

- RDEA119 Produced Significant Beneficial Effect in Animal Models of

Arthritis -

- RDEA594 Shows Promise as an Effective Treatment for Gout -

SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that data will be presented on the Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, demonstrating its potent activity in animal models of arthritis. In addition, the Company will present data on the mechanism of action for RDEA806 and RDEA594 in the area of gout. These data will be presented tomorrow at the 2008 Annual European Congress of Rheumatology Organized by the European League Against Rheumatism (EULAR) in Paris, France.

The extracellular signal-regulated kinase (ERK) pathway plays a critical role in the control of cellular activation, proliferation and the production of inflammatory mediators. Suppression of the ERK pathway by inhibitors of MEK1/2 represents a potential therapeutic approach for treating chronic inflammatory diseases such as rheumatoid arthritis. RDEA119 is a novel selective MEK1/2 inhibitor that was shown to produce a significant beneficial effect in three different animal models of arthritis:

-- Significantly reduced paw swelling in a dose-dependent manner in the

carrageenan-induced paw edema model in rats;

-- Virtually complete reduction in ankle swelling in the adjuvant-induced

arthritis model in rats;

-- Reduced arthritic scores by up to 82% in the collagen antibody-induced

arthritis model in mice.

"We are making excellent progress in all of our inflammation programs. To support the development of RDEA119 in inflammatory diseases, we a
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
2. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
3. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
4. Ardea to Present at Cowen and Companys 28th Annual Health Care Conference
5. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
6. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
7. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
8. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
9. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
10. Ardea Biosciences Announces $40 Million Private Placement
11. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Francisco, CA (PRWEB) July 24, 2014 ... http://www.draperuniversity.com , is proud to announce that ... from 17 different countries will converge on the ... Valley for an intensive, experiential program focused on ... The highly selective school, currently running its sixth ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 The ... of molecular diagnostic test results. It also enables ... for the validation and reporting of high profile ... diagnostics is a rapidly growing area of biotechnology ... genetic predisposition, cancer, and companion diagnostics in personalized ...
(Date:7/23/2014)... strides in saving China,s endangered national treasure, the giant ... panda reserves that have been established and three large ... remain in the wild. , Breeding programs in ... by improving genetic diversity, avoid inbreeding and ultimately, introduce ... high-profile programs doing so far? , In a new ...
(Date:7/23/2014)... 23, 2014  AuraSense Therapeutics, the pioneer in developing ... regulatory and immunotherapeutic agents, announced today that ... Therapeutics, executive leadership team as chief financial ... to joining AuraSense Therapeutics, Mr. Snyder was ... of Cellular Dynamics International Inc., where he ...
Breaking Biology Technology:Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2
... and development will dominate a surge in demand for ... study released this week by a New York consulting ... Lux Research , also projected that sales of ... years. , ,"Interest in nanotechnology focuses on remarkable applications ...
... Fiserv, Inc. and CUNA Mutual Group ... of CUNA Mutual's payment protection products during ... solutions offered by Fiserv business units. The ... protection products, which include credit life, credit disability and ...
... Source: Visions 2005 Madison, Wis. - ... of postage stamp size videos of staid corporate meetings, running ... of the seafloor? , ,Audiences will have the opportunity to ... The Sea" event, hosted locally by the UW-Madison Division ...
Cached Biology Technology:Corporate clients will dominate surge in nanotech tool demand, study projects 2Corporate clients will dominate surge in nanotech tool demand, study projects 3Deep sea event will put spotlight on Internet 2 capabilities 2
(Date:7/24/2014)... sake brewery has its own microbial terroir, meaning the ... those found in the product, creating the final flavor ... journal Applied and Environmental Microbiology . This is ... of a sake brewery. , Many sake makers ... David A. Mills of the University of California, Davis, ...
(Date:7/24/2014)... similar counterparts in humans, affect the connections between nerve ... the hippocampus, an area of the brain that plays ... of memories. The results of the study have been ... function depends on the active communication between nerve cells, ... together into a dense network where they constantly relay ...
(Date:7/24/2014)... researchers and patients have hoped that embryonic stem cells ... bodycould provide insight into numerous diseases perhaps even be ... by the inability to transfer research and tools from ... because human ESCs are "primed" and slightly less plastic ... Powell, and Haoyi Wang, who are scientists in the ...
Breaking Biology News(10 mins):The microbes make the sake brewery 2A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2
... HOBOKEN, N.J. Stevens Institute of Technology,s Center for ... Warning System (EWS) for Inundations in the Dominican Republic. ... DR,s EWS and providing the most up-to-date equipment to ... on the island. , The genesis of the EWS ...
... Wistar Institute and their colleagues have identified, for the first ... of RNA that play a vital role in gene expression ... way to the development of a new generation of cancer ... that blocks the pathway of a particular miRNA, called miR-21, ...
... September 23, 2008 Researchers at Sentara ... explore the safety and effectiveness of stents to open ... Pulmonary Disease (COPD). The EASE (Exhale Airway ... investigational technique without surgery to create new pathways to ...
Cached Biology News:Stevens strengthens Dominican Republic's Early Warning System for Inundations 2Stevens strengthens Dominican Republic's Early Warning System for Inundations 3Scientists identify novel inhibitor of human microRNA 2Scientists identify novel inhibitor of human microRNA 3Sentara begins international trial -- open at only 24 US locations 2
Human VASA Biotinylated Affinity Purified PAb...
[14C]Polyethylene glycol 4000, 9.25 MBq, 250 uCi. Aqueous solution containing 3% ethanol, sterilized. 370-740 MBq/g, 10-20 mCi/g.1.85 MBq/ml, 50 uCi/ml. Category: Radiochemicals &Radiation Safety, ...
... kit for all types of yeast two-hybrid studies, including ... Choice of two bait vectors for ... Triple reporter strain ... Complete set of controls: pLexA-p53, ...
Mouse Limitin MAb (Clone 183727)...
Biology Products: